title: Precision medicine: lessons learned from the SHIVA trial - Authors' reply.
authors.affiliation: Institut Curie, 92210 Saint-Cloud, Paris, France. Electronic address: Christophe.LeTourneau@curie.fr.
authors.forename: Christophe
authors.initials: C
authors.lastname: Le Tourneau
authors.affiliation: Institut Curie, 92210 Saint-Cloud, Paris, France.
authors.forename: Lisa
authors.initials: L
authors.lastname: Belin
authors.affiliation: Institut Curie, 92210 Saint-Cloud, Paris, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Paoletti
authors.affiliation: Institut Curie, 92210 Saint-Cloud, Paris, France.
authors.forename: Ivan
authors.initials: I
authors.lastname: Bièche
authors.affiliation: Institut Curie, 92210 Saint-Cloud, Paris, France.
authors.forename: Maud
authors.initials: M
authors.lastname: Kamal
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D025202:Molecular Diagnostic Techniques; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy*; D057285:Precision Medicine
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor